300 million doses of medications against respiratory and urinary tract infections
Press release : September 27th, 2005

The Swiss family-owned company OM PHARMA invests more than 70 million CHF in biotechnology in Geneva

OM PHARMA opened officially on September 27th, 2005 its new Biotech Production Centre in Meyrin (Geneva). More than 5 years were necessary to implement this state-of-the-art plant, comprising premises and facilities that are among the most up-to-date in Europe. Its so-called “clean rooms” allow the development and production of Broncho-Vaxom® and Uro-Vaxom®, which are marketed in more than 60 countries.
Read full article...